[go: up one dir, main page]

SE8603517L - Heterocykliska foreningar och deras framstellning och farmaceutiska formuleringar - Google Patents

Heterocykliska foreningar och deras framstellning och farmaceutiska formuleringar

Info

Publication number
SE8603517L
SE8603517L SE8603517A SE8603517A SE8603517L SE 8603517 L SE8603517 L SE 8603517L SE 8603517 A SE8603517 A SE 8603517A SE 8603517 A SE8603517 A SE 8603517A SE 8603517 L SE8603517 L SE 8603517L
Authority
SE
Sweden
Prior art keywords
preparation
pharmaceutical formulations
heterocyclic compounds
formula
ion concentration
Prior art date
Application number
SE8603517A
Other languages
English (en)
Other versions
SE465367B (sv
SE8603517D0 (sv
Inventor
C Semeraro
D Micheli
D Pieraccioli
G Gaviraghi
A D Borthwick
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT21958/85A external-priority patent/IT1201455B/it
Priority claimed from IT19480/86A external-priority patent/IT1204458B/it
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of SE8603517D0 publication Critical patent/SE8603517D0/sv
Publication of SE8603517L publication Critical patent/SE8603517L/sv
Publication of SE465367B publication Critical patent/SE465367B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8603517A 1985-08-21 1986-08-20 Heterocykliska foereningar och deras framstaellning och farmaceutiska formuleringar SE465367B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT21958/85A IT1201455B (it) 1985-08-21 1985-08-21 Derivati piridinici sostituiti
IT19480/86A IT1204458B (it) 1986-02-20 1986-02-20 Derivati eterociclici

Publications (3)

Publication Number Publication Date
SE8603517D0 SE8603517D0 (sv) 1986-08-20
SE8603517L true SE8603517L (sv) 1987-02-22
SE465367B SE465367B (sv) 1991-09-02

Family

ID=26327180

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603517A SE465367B (sv) 1985-08-21 1986-08-20 Heterocykliska foereningar och deras framstaellning och farmaceutiska formuleringar

Country Status (18)

Country Link
US (1) US5162345A (sv)
JP (1) JPH0696552B2 (sv)
AT (1) AT394043B (sv)
AU (1) AU588352B2 (sv)
BE (1) BE905297A (sv)
CA (1) CA1337295C (sv)
CH (1) CH669788A5 (sv)
CY (1) CY1554A (sv)
DE (1) DE3628215C2 (sv)
DK (1) DK397686A (sv)
ES (1) ES2001104A6 (sv)
FR (1) FR2586417B1 (sv)
GB (1) GB2181127B (sv)
IE (1) IE59632B1 (sv)
NL (1) NL192385C (sv)
NZ (1) NZ217282A (sv)
SE (1) SE465367B (sv)
SG (1) SG40890G (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine
AU761467B2 (en) * 1998-06-09 2003-06-05 Ajinomoto Co., Inc. Novel enzyme-treated protein-containing food, and methods for producing the same
FR2892412B1 (fr) * 2005-10-26 2008-05-16 Galderma Res & Dev Composes biaromatiques modulateurs des ppars

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455945A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines
DE2228363A1 (de) * 1972-06-10 1974-01-03 Bayer Ag 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
DE2740080A1 (de) * 1977-09-06 1979-03-15 Bayer Ag 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2753946A1 (de) * 1977-12-03 1979-06-13 Bayer Ag 1-n-aryl-1,4-dihydropyridine und ihre verwendung als arzneimittel
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
AU561213B2 (en) * 1983-06-02 1987-04-30 Teijin Limited 1, 4-dihydropyridine derivative
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
IT1204462B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
DE3607821A1 (de) * 1986-03-08 1987-09-10 Bayer Ag Aminoester-dihydropyridine, verfahren zur herstellung und ihre verwendung
US4814455A (en) * 1986-04-16 1989-03-21 Bristol-Myers Company Dihydro-3,5-dicarboxylates

Also Published As

Publication number Publication date
AT394043B (de) 1992-01-27
SG40890G (en) 1990-08-03
JPH0696552B2 (ja) 1994-11-30
CA1337295C (en) 1995-10-10
SE465367B (sv) 1991-09-02
AU6166886A (en) 1987-02-26
GB2181127B (en) 1989-08-02
BE905297A (fr) 1987-02-20
FR2586417B1 (fr) 1991-08-30
CY1554A (en) 1991-03-22
NL8602117A (nl) 1987-03-16
IE862227L (en) 1987-02-21
CH669788A5 (sv) 1989-04-14
NL192385C (nl) 1997-07-04
AU588352B2 (en) 1989-09-14
NZ217282A (en) 1989-01-27
IE59632B1 (en) 1994-03-09
SE8603517D0 (sv) 1986-08-20
FR2586417A1 (fr) 1987-02-27
DE3628215A1 (de) 1987-02-26
GB8620217D0 (en) 1986-10-01
NL192385B (nl) 1997-03-03
ES2001104A6 (es) 1988-04-16
DK397686D0 (da) 1986-08-20
ATA223986A (de) 1991-07-15
US5162345A (en) 1992-11-10
DK397686A (da) 1987-02-22
JPS6296467A (ja) 1987-05-02
GB2181127A (en) 1987-04-15
DE3628215C2 (de) 1996-09-19

Similar Documents

Publication Publication Date Title
SE8300736D0 (sv) Novel pharmacologically active compounds
ES491225A0 (es) Procedimiento para la preparacion de 2,4-diamino-pirimidin-5-carbanilidas
IL76457A0 (en) Tetralin derivatives,their preparation and pharmaceutical compositions containing them
FI872864A0 (sv) Förfarande för framställning av farmaceutiskt aktiva bensimidazolföreningar
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
ES521086A0 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
ES8505379A1 (es) Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
DK408083D0 (da) Isoquinilinderivater, deres fremstilling og anvendelse
SE8603517L (sv) Heterocykliska foreningar och deras framstellning och farmaceutiska formuleringar
KR900011717A (ko) 페닐히드라존, 이들의 제조방법 및 이들로부터 제조된 치료 및 미용 조성물
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
DK527186D0 (da) Bronchodilaterende farmaceutisk praeparat
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
DK313587D0 (da) Tetrahydrobenzothiazolforbindelser, deres fremstilling og anvendelse
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
SE8004383L (sv) Farmaceutisk beredning for oral administrering och forfarande for dess framstellning
PT82847B (pt) Processo para a preparacao de composicoes farmaceuticas contendo 4-amino-2-(imidazolodina-2-ona-1-il)-pirimidina-5-carboxil-(n-(3-trifluormetil-fenil)-amidas)
FR2703048B1 (fr) Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
MY101266A (en) Pharmaceutical formulations
DK10187A (da) Methioninsubstituerede 1,4-dihydropuyridiner, deres fremstilling og anvendelse som laegemidler
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
NZ220539A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
RU92016559A (ru) Производные диалкокси-пиридинилбензимидазола, фармацевтическая композиция, способ ингибирования или лечения, способ их получения, применение и промежуточные соединения

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8603517-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8603517-7

Format of ref document f/p: F